Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1097/QAD.0b013e32832aadf2

Type

Journal article

Journal

AIDS

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

15/05/2009

Volume

23

Pages

1005 - 1013

Keywords

Science & Technology, Life Sciences & Biomedicine, Immunology, Infectious Diseases, Virology, IMMUNOLOGY, INFECTIOUS DISEASES, VIROLOGY, acyclovir, HIV, herpes simplex virus type 2, suppressive therapy, transmission, valacyclovir, viral load, PLACEBO-CONTROLLED TRIAL, RNA LEVELS, HETEROSEXUAL TRANSMISSION, GENDER-DIFFERENCE, DOUBLE-BLIND, WOMEN, ACYCLOVIR, INFECTION, METAANALYSIS, ACQUISITION